<unk>  is an oxazolidinone-class antibacterial that is FDA approved for the treatment of following infections caused by susceptible gram-positive bacteria: nosocomial pneumonia; community-acquired pneumonia; complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis; uncomplicated skin and skin structure infections; vancomycin-resistant enterococcus faecium infections.   Common adverse reactions include diarrhea, vomiting, headache, nausea, and anemia.
Linezolid
Meropenem
Teicoplanin
Vancomycin 
Ramoplanin
Biapenem
Daptomycin
Ertapenem